ID   GOT1
AC   CVCL_L306
SY   GOTeborg 1
DR   Wikidata; Q54871614
RX   PubMed=11159212;
RX   PubMed=22538498;
RX   PubMed=29444910;
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Heterozygous (PubMed=29444910).
CC   Omics: Array-based CGH.
CC   Omics: SNP array analysis.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=29444910
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D21S11: 30,31.2
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C6422; Midgut neuroendocrine tumor G1
DI   ORDO; Orphanet_100093; Carcinoid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 12
//
RX   PubMed=11159212; DOI=10.1016/S0002-9440(10)64017-5; PMCID=PMC1850312;
RA   Kolby L., Bernhardt P., Ahlman H., Wangberg B., Johanson V.,
RA   Wigander A., Forssell-Aronsson E., Karlsson S., Ahren B., Stenman G.,
RA   Nilsson O.;
RT   "A transplantable human carcinoid as model for somatostatin
RT   receptor-mediated and amine transporter-mediated radionuclide uptake.";
RL   Am. J. Pathol. 158:745-755(2001).
//
RX   PubMed=22538498; DOI=10.1159/000338793;
RA   Grozinsky-Glasberg S., Shimon I., Rubinfeld H.;
RT   "The role of cell lines in the study of neuroendocrine tumors.";
RL   Neuroendocrinology 96:173-187(2012).
//
RX   PubMed=29444910; DOI=10.1530/ERC-17-0445; PMCID=PMC5827037;
RA   Hofving T., Arvidsson Y., Almobarak B., Inge L., Pfragner R.,
RA   Persson M., Stenman G., Kristiansson E., Johanson V., Nilsson O.;
RT   "The neuroendocrine phenotype, genomic profile and therapeutic
RT   sensitivity of GEPNET cell lines.";
RL   Endocr. Relat. Cancer 25:367-380(2018).
//